Dr. Travis Biechele, PhD

VP and Head of Research at Shasqi

Speaker

Dr. Travis Biechele has been designing, characterizing, and developing bioconjugates for the past 13 years. Prior to joining Shasqi as VP of Research, he was a Senior Principal Scientist in the Discovery Biologics organization at Merck where he was leading bioconjugate therapeutic programs and bioconjugate targeting modality innovation. Prior to joining Merck, he was a Director at Seagen leading multiple ADC therapeutic programs and a systems-guided biology team encompassing target characterization, in vitro and in vivo pharmacology, and AI/ML powered predictive modeling to guide therapeutic hypothesis generation. Travis received his PhD in pharmacology and postdoctoral training at the University of Washington and Howard Hughes Medical Institute.